BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32004107)

  • 1. How We Approach Smoldering Multiple Myeloma.
    Raje N; Yee AJ
    J Clin Oncol; 2020 Apr; 38(11):1119-1125. PubMed ID: 32004107
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Nodular Lymphocyte Hodgkin Lymphoma: The Goldilocks Principle.
    Bartlett NL
    J Clin Oncol; 2020 Mar; 38(7):662-668. PubMed ID: 31922929
    [No Abstract]   [Full Text] [Related]  

  • 3. Tailored Approaches to Induction Therapy for Acute Promyelocytic Leukemia.
    DeAngelo DJ
    J Clin Oncol; 2017 Feb; 35(6):583-586. PubMed ID: 28095152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not.
    Knisely JPS; Fine HA
    J Clin Oncol; 2023 Feb; 41(6):1183-1188. PubMed ID: 36260825
    [No Abstract]   [Full Text] [Related]  

  • 5. Late Recurrence Following Early Breast Cancer.
    Thomas A; Parsons HA; Smith KL
    J Clin Oncol; 2022 May; 40(13):1400-1406. PubMed ID: 35239445
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation.
    Rubenstein JL
    J Clin Oncol; 2022 Nov; 40(32):3681-3687. PubMed ID: 36179277
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement.
    Smith BD; Goetz MP; Boughey JC
    J Clin Oncol; 2020 Jul; 38(20):2290-2298. PubMed ID: 32442073
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized Approach.
    Larocca A; Palumbo A
    J Clin Oncol; 2016 Oct; 34(30):3600-3604. PubMed ID: 27601551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Approaches for Platinum-Resistant Ovarian Cancer.
    St Laurent J; Liu JF
    J Clin Oncol; 2024 Jan; 42(2):127-133. PubMed ID: 37910841
    [No Abstract]   [Full Text] [Related]  

  • 10. Duress and Distress Versus a Neurocognitive Mess: The Challenges of Procedural Sedation in Pediatric B-ALL.
    Turcotte LM; Neglia JP
    J Clin Oncol; 2024 Jun; ():JCO2400472. PubMed ID: 38917374
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of Minimally Invasive Techniques in the Management of Early-Stage Carcinoma of the Uterine Cervix.
    Bercow A; Del Carmen MG; Rauh-Hain JA; Melamed A
    J Clin Oncol; 2024 Jun; ():JCO2400656. PubMed ID: 38917386
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgery No More? Managing the Primary Tumor in Stage IV Breast Cancer.
    Anderson DN; Port ER
    J Clin Oncol; 2022 Mar; 40(9):927-931. PubMed ID: 35119913
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating Advanced Head and Neck Cancer When Cisplatin Is Not an Option.
    Jhawar SR; Bonomi M; Harari PM
    J Clin Oncol; 2021 Jan; 39(1):7-12. PubMed ID: 33275489
    [No Abstract]   [Full Text] [Related]  

  • 14. Revisiting the Threshold for Cancer Genetics Referral in Patients With Wilms Tumor.
    Turner JT; Hill DA; Dome JS
    J Clin Oncol; 2022 Jun; 40(17):1853-1860. PubMed ID: 35500208
    [No Abstract]   [Full Text] [Related]  

  • 15. Late Breast Cancer Survivorship: Side Effects and Care Recommendations.
    Jahan N; Cathcart-Rake EJ; Ruddy KJ
    J Clin Oncol; 2022 May; 40(15):1604-1610. PubMed ID: 35226513
    [No Abstract]   [Full Text] [Related]  

  • 16. Consolidation Therapy for Acute Myeloid Leukemia: Defining a Benchmark.
    Luger SM
    J Clin Oncol; 2021 Mar; 39(8):870-875. PubMed ID: 33411591
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event.
    Nakajima EC; Lipson EJ; Brahmer JR
    J Clin Oncol; 2019 Oct; 37(30):2714-2718. PubMed ID: 31461381
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition.
    Hicks D; O'Regan RM
    J Clin Oncol; 2022 Apr; 40(11):1142-1146. PubMed ID: 35201844
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy for Muscle-Invasive Urothelial Carcinoma: Controversies and Dilemmas.
    Sonpavde GP; Mouw KW; Mossanen M
    J Clin Oncol; 2022 Apr; 40(12):1275-1280. PubMed ID: 35271295
    [No Abstract]   [Full Text] [Related]  

  • 20. Feeding the Controversy: When Pelvic Irradiation Improves Outcomes in High-Risk and Very High-Risk Prostate Cancer.
    Jan I; Parikh RR
    J Clin Oncol; 2021 Apr; 39(11):1196-1202. PubMed ID: 33683923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.